期刊文献+

溴化氰活化法和胺还原法制备的A群、C群脑膜炎球菌多糖蛋白结合物生化及免疫学特性比较 被引量:4

Biochemical and immunological characteristics of group A and group C meningococcal polysaccharide-tetanus toxoid conjugates prepared by cyanogen bromide activation and amine reduction
原文传递
导出
摘要 目的:比较溴化氰活化法和胺还原法制备A群和C群脑膜炎球菌多糖(group A and group C meningococcal polysaccharide,GAMP和GCMP)蛋白结合物的生化及免疫学特性。方法:以GAMP和GCMP为抗原,破伤风类毒素(tetanus toxoid,TT)为载体蛋白,采用溴化氰活化法和胺还原法制备结合物,并对其进行生化及免疫学检测。结果:两种方法均可将多糖与TT有效结合,在小鼠体内均具有良好的免疫原性。溴化氰活化法制备的结合物收率、高分子结合物含量、免疫小鼠产生的抗体效价更高。结论:采用溴化氰活化法制备GAMP-TT,GCMP-TT结合物优于胺还原法。 Objective: To compare the biochemical and immunological characteristics of tetanus toxoid( TT) conjugated group A and group C meningococcal polysaccharide( GAMP and GCMP) prepared by cyanogen bromide activation and amine reduction, respectively. Methods: GAMP-TT and GCMP-TT conjugates were prepared by cyanogens activation and amine reduction using GAMP and GCMP as polysaccharide antigens and TT as carrier protein. Their biochemical and immunological characteristics were analyzed. Results: Polysaccharides and TT were bound effectively by the two methods,and the resulted conjugates showed good immunogenicity in NIH mice. The GAMP-TT and GCMP-TT prepared by cyanogen bromide activation had higher yield,and higher molecular conjugate content and the antibody titer than those prepared by amine reduction. Conclusion: Cyanogen bromide activation is more suitable for the preparation of GAMP-TT and GCMP-TT than amine reduction.
出处 《中国新药杂志》 CAS CSCD 北大核心 2016年第21期2441-2445,共5页 Chinese Journal of New Drugs
基金 国家"重大新药创制"科技重大专项资助项目(2013ZX09402302)
关键词 脑膜炎球菌多糖 结合疫苗 结合方法 meningococcal polysaccharide conjugate vaccine conjugation methods
  • 相关文献

参考文献16

  • 1王燕,王秉瑞,谢贵林.结合疫苗概述[J].微生物学免疫学进展,2000,28(1):60-63. 被引量:4
  • 2DICK WE,BEURRET M. Glycoconjugates of bacterial carbohy-drate antigens. A survey and consideration of design and prepara-tion factors[J]. Contrib Microbiol Immunol,1989,10: 48 -114.
  • 3RODRIGUEZ ME,DOBBELSTEEN GP,OOMEN LA,et al.Immunogenicity of streptococcus pneumoniae type 6B and 14 pol-ysaccharide-tetanus toxoid conjugates and the effect of uncoupledpolysaccharide on the antigen-specific immune response [J].Vaccine,1998,16( 20) : 1941 - 1949.
  • 4LAFERRIERE CA,SOOD RK,MUYS JM,et al. The synthesisof streptococcus pneumoniae polysaccharide-tetanus toxoid conju-gates and the effect of chain length on immunogenicity[J]. Vac-cine,1997,15( 2) : 179 - 186.
  • 5GUO Z,JENNIN GS. Protein-polysaccharide conjugation[J].Methods Mol Med. 2001,66( 66) : 49 - 54.
  • 6张涛,孟欣,朱涛,刘正,张立平,郝杰清.3型肺炎球菌荚膜多糖结合疫苗的研制[J].中国免疫学杂志,2015,31(10):1361-1365. 被引量:6
  • 7周觉非,姚静,尹丹丹,陈思,杨溢尧,代洁,张珂,饶海林,李春阳,江山,张雪梅.19F型肺炎球菌荚膜多糖与载体蛋白P64K结合物的制备及免疫原性[J].中国新药杂志,2012,21(10):1131-1134. 被引量:4
  • 8刘方蕾,吴兵,候亚莉,王欣茹,王晶,于旭博,刘佳,孔素娟,赵志强,谢贵林.23F型肺炎球菌家兔免疫血清的制备及其在免疫学方法中的特异性研究[J].中国新药杂志,2014,23(10):1133-1138. 被引量:4
  • 9COHN AC,MACNEIL JR,CLARK TA,et al. Prevention andcontrol of meningococcal disease: recommendations of the Adviso-ry Committee on Immunization Practices ( ACIP) [J]. MMWRRecomm Rep,2013,62( RR-2) : 1 - 28.
  • 10NOVAK RT,KAMBOU JL,DIOMAND FV,et al. SerogroupA meningococcal conjugate vaccination in Burkina Faso: analysisof national surveillance data[J]. Lancet Infect Dis,2012,12( 10) : 757 - 764.

二级参考文献48

  • 1王艳萍,缪蕾,钱幼琼,梁娟,吴艳乔,朱军,代礼,周光萱.1996至2000年全国5岁以下儿童死亡监测主要结果分析[J].中华预防医学杂志,2005,39(4):260-264. 被引量:115
  • 2鲜墨,吴忠道.肺炎链球菌感染的流行病学及毒力因子研究进展[J].热带医学杂志,2006,6(6):740-742. 被引量:15
  • 3陆权.儿童社区获得性肺炎管理指南(试行)(上)[J].中华儿科杂志,2007,45(2):83-90. 被引量:607
  • 4LEE C J, BANKS SD, LI JP, Virulence, immunity and vaccine related to streptococcus pneumonia [ J ]. Crit Rev Microbiol, 1991, 18(2): 89-114.
  • 5LEE HJ, KANG JH, HENRICHSEN J, et al. Immunogenicity and safety of a 23-valent Pneumocaccal polysaccharide vaccine in healthy children and in children at increased risk of Pneumocac- calinfection[J]. Vaccine, 1995, 13(16): 1533-1538.
  • 6Pt~REZ AE, DICKINSON FO, BANDERAS F, et al. Safety and preliminary immunogenicity of MenC/P64k, a meningococcal se- rogroup C conjugate vaccine with a new recombinant carrier[ J]. FEMS Immunol Med Microbiol, 2006, 4-6 ( 3 ) : 386 - 392.
  • 7CARMENATE T, CANAAN L, ALVAREZ A, et al. Effect of conjugation methodology on the immunogenicity and protective ef- ficacy of meningococcal group C polysaccharide-P64k protein con-jugates[ J ]. FEMS lmmunol Med Microbiol, 2004, 40 (3) : 193 - 199.
  • 8KIM JS, LASKOWICH ER, MICHON F, et al. Monitoring acti- vation sites on polysaccharides by GC-MS [ J ]. Anal Biochem, 2006, 358(1) : 136 -142.
  • 9ANDERSON P, PICHICHERO ME, INSELRA. Immunogens consisting of oligosaccharides from the capsule of haemophilus in- fluenzae type b coupled to diphtheria toxoid or the toxin protein CRM197[J]. JClinlfvest, 1985, 76(1) :52 -59.
  • 10LEE A, NELSON BL, MOND JJ. Activation of soluble polysae- charides with 1-cyano-4-dimethylaminopyridinium tetrafluorobo- rate for use in protein-polysaccharide conjugate vaccines and im- munological reagents[J]. Vaccine, 1996, 14(3): 190-198.

共引文献14

同被引文献46

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部